Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 4 (INTS4) is a scaffold protein that is an essential component of the Integrator complex, a multi-protein complex associated with RNA polymerase II. INTS4 is required for the assembly of the Integrator cleavage module together with INTS9 and INTS11, which is involved in the endonucleolytic 3′-end processing of small nuclear RNAs (UsnRNAs) and enhancer RNAs. In mammalian cells, INTS4 plays a critical role in maintaining Cajal body and histone locus body integrity, necessary for proper RNA biogenesis. INTS4 physically interacts with INTS9/11 through its N-terminal HEAT repeats and C-terminal β-sheet-rich region. Loss of INTS4 disrupts snRNA processing and nuclear body assembly, affecting global RNA maturation pathways. While essential for RNA biology, INTS4 is not considered a current therapeutic target nor is it known to be implicated directly in human disease[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 4 (INTS4).